Trading ahead of expectations
Summary by AI BETAClose X
5 September 2025
Peel Hunt Limited
("Peel Hunt", the "Company" or the "Group")
Trading ahead of expectations
The Group has had a strong start to the current financial year ("FY26") demonstrating the strategic progress made by the business during the challenging market conditions of the last three years.
In Investment Banking, we have acted on a number of substantial M&A transactions. Our corporate franchise now includes 58 FTSE 350 clients (5 FTSE 100 companies and 53 FTSE 250 companies) and in recent weeks we have seen nascent ECM activity where we have supported our clients on a number of equity raises and block trades. Revenues in our Execution Services business are also encouraging and materially ahead of the equivalent prior year period.
As a result of this activity, we expect to deliver full year results ahead of market expectations. The Company will update the market on revenues for the first six months of FY26 on 1 October 2025.
The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 ("UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
For further information, please contact:
Peel Hunt: via Sodali & Co
Steven Fine, CEO
Michael Lee, COO
Billy Neve, Group Finance Director
Sodali & Co (Financial PR): +44 (0)20 7100 6451
Justin Griffiths
Gilly Lock
Russ Lynch
peelhunt@sodali.com
Grant Thornton UK LLP (Nominated Adviser): +44 (0)20 7383 5100
Philip Secrett
Colin Aaronson
Elliot Peters
Keefe, Bruyette & Woods (Corporate Broker): +44 (0) 20 7710 7600
Alistair McKay
Alberto Moreno Blasco
Fred Walsh
Notes to editors
About Peel Hunt
Peel Hunt is a leading UK investment bank that specialises in supporting mid-cap and growth companies. It provides integrated investment banking advice and services to UK corporates, including equity capital markets, private capital markets, M&A, debt advisory, investor relations and corporate broking. The Company's joined up approach combines these services with expert research and distribution and an execution services hub that provides liquidity to the UK capital markets, delivering value to global institutions and trading counterparties alike. The Company is admitted to trading on AIM (LON: PEEL) and has offices in London, New York and Copenhagen.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 16 minutes ago City of London Investment Group
- 23 minutes ago BioPharma Credit
- 26 minutes ago BioPharma Credit
- 27 minutes ago Diageo
- 32 minutes ago Barr (A.G.)